World's Best Scientists 2026 revealed!
Wolf-Henning Boehncke

Wolf-Henning Boehncke

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
23195
World Ranking
5003
National Ranking
97

Overview

Wolf-Henning Boehncke is affiliated with the University of Geneva in Switzerland. Their academic output is primarily situated within the fields of Medicine and Immunology and Microbiology, with significant contributions to related subfields such as Immunology, Rheumatology, Dermatology, Hematology, and Pathology and Forensic Medicine.

The scientist's research topics encompass:

  • Psoriasis: Treatment and Pathogenesis
  • Spondyloarthritis Studies and Treatments
  • Dermatology and Skin Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical studies and practices

Frequent publication venues for Wolf-Henning Boehncke include:

  • Annals of the Rheumatic Diseases
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of the American Academy of Dermatology
  • Revue Médicale Suisse

Collaborative work is an essential component of their research, with frequent coauthors including:

  • Nicolò Costantino Brembilla
  • Christopher T. Ritchlin
  • A. Kollmeier
  • Iain B. McInnes
  • Philip J. Mease

Some of the notable recent papers authored or coauthored by Wolf-Henning Boehncke are:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update, 2020, Annals of the Rheumatic Diseases
  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial, 2020, The Lancet
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update, 2024, Annals of the Rheumatic Diseases
  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications, 2020, Frontiers in Immunology

Best Publications

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

    Wolf-Henning Boehncke;Sandra Boehncke;Anne-Marie Tobin;Brian Kirby

  • The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

    Nicolo Costantino Brembilla;Luisa Senra;Wolf-Henning Boehncke;Wolf-Henning Boehncke

  • S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    Alexander Nast;Wolf-Henning Boehncke;Ulrich Mrowietz;Hans-Michael Ockenfels

  • Psoriasis patients show signs of insulin resistance.

    Sandra Boehncke;Diamant Thaci;Heike Beschmann;Ralf J. Ludwig

  • Biological therapies in the systemic management of psoriasis: International Consensus Conference.

    W. Sterry;J. Barker;W.H. Boehncke;J.D. Bos

  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

    Atul Deodhar;Philip S Helliwell;Wolf-Henning Boehncke;Alexa P Kollmeier

  • Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.

    Wolf-Henning Boehncke

  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

    Peter Nash;Andreas Kerschbaumer;Thomas Dörner;Maxime Dougados

  • The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis

    G Girolomoni;R Strohal;L Puig;H Bachelez;H Bachelez

  • Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis

    Ralf J. Ludwig;Beatrice Boehme;Maurizio Podda;Reinhard Henschler

  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.

    Esther von Stebut;Wolf-Henning Boehncke;Wolf-Henning Boehncke;Kamran Ghoreschi;Tommaso Gori

  • Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.

    Atul Deodhar;Alice B Gottlieb;Wolf-Henning Boehncke;Wolf-Henning Boehncke;Bin Dong

  • Etiology and Pathogenesis of Psoriasis.

    Wolf-Henning Boehncke

  • Managing comorbid disease in patients with psoriasis

    Wolf-Henning Boehncke;Sandra Boehncke;Michael P Schön

  • Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.

    Steven Kozlowski;Toshiyuki Takeshita;Wolf-Henning Boehncke;Hidemi Takahashi;Hidemi Takahashi

  • Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.

    Sandra Boehncke;Rebekka Salgo;Jurate Garbaraviciene;Heike Beschmann

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Ulrich Mrowietz
Ulrich Mrowietz Kiel University
Matthias Augustin
Matthias Augustin Universität Hamburg
Ralf Ludwig
Ralf Ludwig University of Rostock
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Kristian Reich
Kristian Reich University of Göttingen
Philip J. Mease
Philip J. Mease University of Washington
Michael P. Schön
Michael P. Schön University of Göttingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens many doors to healthcare and research-oriented careers. As the demand for healthcare professionals grows, many students are exploring flexible education pathways. For example, students interested in medical imaging may pursue online rad tech programs to build skills in radiology technology while balancing work and study.

Nutrition is a fast-growing field related to biochemistry, and the best dietetics masters programs offer advanced training for those aiming for a career as a registered dietitian. Another in-demand option is becoming a medical assistant, with many choosing an online medical assisting school that provides convenient, accredited healthcare training and may include financial aid opportunities.

Those already certified as medical assistants can advance their careers through a cma to lpn bridge program online, gaining new skills and entering higher-paying nursing roles. These online degree pathways make it easier to transition into specialized healthcare professions, building on a foundation in Biology and Biochemistry.

Best Scientists Citing Wolf-Henning Boehncke

Trending Scientists

Recently Published Articles